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Introduction
Hemangiopericytoma (HPC) is a tumor arising from
Zimmerman’s pericytes that was first described in 1942
by Stout and Murray.1 HPC usually occurs in the sub-
cutaneous soft tissue and skeletal system, but rarely
within the central nervous system (CNS). The inci-
dence of CNS HPC is around 1% of all CNS tumors.2
Most CNS HPCs are found in the cranial cavity; they
rarely occur in the spinal canal. To date, only 52 cases
of intraspinal HPCs have been reported.3–20 Most of
the intraspinal HPCs involve the extradural structures.
There were only 10 intradural HPCs reported and all
were extramedullary lesions.3,5,10,14,17 Intramedullary
invasion has never been reported. HPCs are well known
for their high recurrence and metastatic rates. A recent
review reported a local recurrence rate of 55% and a
metastatic rate of 17%.21 Some intraspinal HPCs are
due to recurrence or metastasis from other primary
intracranial lesions,15,19,20 while others are primary
intraspinal HPCs.
What constitutes the ideal treatment for CNS HPC
remains uncertain. Most neurosurgeons suggest gross-
total resection for both neural decompression and
pathology diagnosis. Whether adjuvant radiotherapy
would help to reduce the rate of recurrence and pro-
long the length of survival is unclear. Despite aggressive
treatment, the 5-year recurrence rate is still around
62–65%.2,22
Here, we report a case of primary intradural HPC
with intramedullary invasion in the thoracic spine. It
was successfully managed by gross-total resection. So
far, over the course of a 3-year follow-up period, no
recurrence has been found. We also review the litera-
ture on intraspinal HPCs with regard to their clinico-
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Case Report
An 80-year-old, previously healthy, man was admitted
to our neurosurgery department due to progressive
weakness of both legs for 3 months. History-taking
revealed that he had begun to suffer from numbness
and a tingling sensation in both legs 6 months pre-
viously, which was followed by weakness and gait 
disturbance. Just prior to this hospitalization, urine
incontinence occurred.
On examination, a sensory impairment below the
umbilicus was found. The deep tendon reflexes of the
legs were exaggerated. Paraparesis with only grade 2
muscle power of both legs was noted. An anorectal
digital exam showed preserved anal tone. Ophthal-
mological and cranial nerve examinations were normal.
Biochemical laboratory studies were unremarkable
except for a mildly elevated white blood cell count
(11,700/mm3). An intraspinal lesion in the thoracic
spine around T10 was suspected.
Magnetic resonance imaging (MRI) of the thoracic
spine showed a dumbbell-shaped, posteriorly-located
intradural tumor at T10 with severe cord compression.
The tumor had an isointense signal on T1-weighted
imaging and a hyperintense signal on T2-weighted
imaging (Figure 1A). After injecting gadolinium-di-
ethylenetriaminepenta-acetic acid (Gd-DTPA), the
tumor was enhanced homogeneously (Figure 1B). Pri-
mary neurogenic tumor, meningioma or metastatic
lesion was considered. A thorough survey for metas-
tasis showed no other primary site. MRI of the rest of
the spine showed an old compression fracture at the
T12 vertebral body and no other significant abnor-
mality. Brain MRI showed nothing remarkable.
The patient underwent total laminectomy from
T9 to T11. After dura opening, a well-vascularized
tumor was found. The tumor was mainly on the sur-
face of the spinal cord, with intramedullary invasion
(Figure 2A). The extramedullary part was removed first




Figure 1. (A) Preoperative sagittal T2-weighted magnetic reso-
nance imaging (MRI) revealed an intradural tumor (arrow) at T10
with a hyperintense signal. Also noted was an old compression
fracture at the T12 vertebral body. (B) Preoperative axial cut of
T1-weighted enhanced MRI showed that the tumor enhanced
homogeneously after Gd-DTPA injection. There was a thin plane
between the intradural and intramedullary part of the tumor,
causing it to form a dumbbell shape (arrow). This indicated that
the tumor had invaded into the spinal cord. The remaining spinal
cord was compressed and deformed greatly (*). (C) Post-
operative sagittal T2-weighted MRI showed that the tumor was
completely removed.
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into the cord tissue and removed under meticulous
dissection (Figures 2C and 2D). Hemorrhaging during
tumor removal was more profuse than with intradural
meningioma or neurofibroma removal, but remained
under control. The tumor was removed completely.
Intraoperative frozen-section examination showed a
well-vascularized meningioma.
Postoperatively, the patient’s neurological function
gradually improved. Follow-up MRI of the thoracic
spine showed no residual tumor or tumor recurrence
(Figure 1C). He has been followed for 3 years and con-
tinues to do well, with no evidence of disease recurrence.
The formal pathology report was as follows: grossly,
the tumor was well-circumscribed, and on cut section,
it was firm to rubbery with a gray-tan nodular surface.
Under light microscope, the tumor was densely cellular
with abundant vasculature. The vessels formed a con-
tinuous ramifying vascular network that exhibited
striking variation in caliber, and some of them had
staghorn appearance (Figure 3A). The neoplastic cells
proliferated between the vessels, sometimes compress-
ing them to the point of obscuring them. The neo-
plastic cells were round, ovoid to slightly spindled,
and had scant cytoplasm. Anaplastic features, such as
hypercellularity, pleomorphism, > 5 mitoses per 10
high-powered fields and necrosis, were not identified.
The tumor had a rich network of reticulin fibers 
surrounding individual cells (Figure 3B). The tumor
cells were immunoreactive for smooth muscle-specific
actin (Figure 3C) and vimentin, but non-reactive for
CD34 and S-100 protein. The above findings were
compatible with HPC.
Discussion
HPC is a rare, highly vascularized neoplasm arising




Figure 2. Intraoperative pictures of the tumor removal process. (A) After dura opening, a well-vascularized tumor mass (arrow) was
found on the cord surface with intramedullary invasion. (B) The extramedullary part was removed first. (C) Next, the intramedullary part
was followed into the cord tissue and removed under meticulous dissection (arrow indicates the pia opening). (D) The tumor was com-
pletely removed (arrows indicate the suture retraction of the pia mater).
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that normally surround reticular sheath capillaries.1
HPC usually occurs in the subcutaneous soft tissue and
skeletal system, and rarely within the CNS. A number
of series of meningeal HPCs have already been
reported.2,10,12,21,23,24 For intraspinal HPCs, due to
their rarity, only several case reports and small case
series were found. A literature review showed that
there were 52 intraspinal HPCs reported, including
41 extradural HPCs and 11 intradural HPCs (includ-
ing the present case).3–20 Eighteen were in the cervical
spine, 22 in the thoracic spine (including the present
case), 5 in the lumbar spine, 1 in the sacrum, and 6
were unknown.3–20 Most of the reported intraspinal
HPCs were included in the meningeal HPC series
without any detailed descriptions of their clinical behav-
ior, treatment and outcome.2,12,23,24 Guthrie et al in
1989 reported a series of 44 meningeal HPCs, with
only 2 in the spine.2 A series reported in 2003 by
Ecker et al included 38 HPCs, with 3 found in the
spine.24 In 1958, Schirger et al were the first to describe
this neoplasm of the spine.15 Since then, 51 addi-
tional cases have been reported.3–14,16–20 Most of the
intraspinal HPCs occurred in the extradural region
such as the vertebral body, lamina, pedicle or epidural
space. In 1961, Kruse10 was the first to report an 
intradural spinal HPC. Since then, 9 additional cases
have been reported.3,5,14,17 All of them were found in
the intradural extramedullary region.
The MRI characteristics of intraspinal and intra-
cranial HPCs are the same. They usually have an isoin-
tense signal on T1-weighted imaging and hyperintense
signal on T2-weighted imaging. After Gd-DTPA
injection, HPCs enhance homogeneously.2,3,17 When
an extradural HPC grows and expands, it sometimes
erodes the adjacent bony structures such as the lamina,
pedicle, neural foramen and even paraspinal muscle.
The expansion of extradural HPCs through the neural
foramen will form the characteristic dumbbell-shape
appearance on MRI.17 Since HPC is a tumor that
arises from the pericytes of capillaries, it is possible that
HPC may follow the cord surface vessels to invade cord
tissue, as was observed in the present case. This is dif-
ferent from intradural meningioma or neurofibroma,
which occur purely in the extramedullary space and
have a good surgical “plane” during dissection. The




Figure 3. Tumor histopathology. (A) The specimen showed typical
characteristics of a hemangiopericytoma with dense cellularity and
classic staghorn vessels (hematoxylin & eosin, 100×). (B) There is a
rich network of reticulin fibers surrounding individual cells (reticulin
stain, 400×). (C) The tumor cells stain positive for smooth muscle-
specific actin (400×).
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showed a dumbbell-shaped tumor with suspected
intramedullary invasion. This is different from the
known expansion type which is usually observed in
other extradural HPCs because in the present case, the
dumbbell shape was observed purely in the intradural
region. To the best of our knowledge, there are no
previous reports with this type of finding. We care-
fully inspected the relation of the tumor and spinal
cord and then dissected inside the cord for total
removal. In previous articles, most neurosurgeons
recommend en bloc resection to reduce intraoperative
blood loss and recurrence rate.2,3,21 But when tumor
with severe neural compression is encountered, cen-
tral debulking and piecemeal removal may be needed
to reduce neural damage, which is what we did in our
case. Significant intraoperative blood loss used to be a
major problem.2,5,13,22,24 But by utilizing modern
microsurgical techniques, improved preoperative imag-
ing surveys and better neurointensive care, periopera-
tive mortality and morbidity rates have been reduced
a lot.
A further analysis of the 52 intraspinal HPCs
showed that there were 25 extradural HPCs and 
9 intradural HPCs with follow-up data. The overall
recurrence rate was 53%. There were 14 (56%) recur-
rences in the extradural HPC group and 4 (44%) in
the intradural HPC group. Statistical analysis using
Fisher’s exact test showed no significant difference
(p = 0.42). Further analysis between extradural and
intradural HPCs showed that intradural HPCs harbor
a higher chance of gross-total removal. Gross-total
removal was achieved in 9 cases (including the pres-
ent case) among all 11 (82%) intradural HPCs, which
was significantly higher than the 15 of 41 (38%)
extradural HPCs (p < 0.05). The lower rate of gross-
total resection of extradural HPCs may be due to
their firm adherence to the dura mater, irregular inva-
sion of the bone, and rich vascularization. Preoperative
embolization may help in bleeding control and better
removal.5,12,13 It should be remembered, however,
that if severe compression already exists, embolization
may lead to clinical deterioration, probably caused by
tumor swelling, and emergent surgery may be
needed. Also, after extensive removal of extradural
HPC, some type of fusion and fixation device may be
needed to reconstruct the destroyed bony structure.16
All of these issues make extradural HPC removal dif-
ficult. The surgical strategy for intradural HPC
removal is much simpler as long as the HPC can be
freed from neighboring nerve tissue. Guthrie et al2
reported that total tumor resection favorably affected
recurrence and survival, although this did not reach
statistical significance. In a recent series reported by
Ecker et al,24 gross-total resection did not provide any
significant survival benefit. Our analysis showed that
gross-total resection had no benefit in reducing recur-
rence rate. A possible reason for this may be that HPC
is a highly malignant tumor that is prone to recur-
rence and metastasis. Standard surgical eradication may
fail to control disease progression. Furthermore, recur-
rence and metastasis may occur very late after the first
operation.15,19,20,25 A long follow-up period is thus
mandatory.
Radiotherapy was once advocated to reduce recur-
rence rate and improve length of survival for CNS
HPCs.2,12,22,26–28 Guthrie et al found that adjuvant
radiation therapy extended the average time before
first recurrence and extended the survival period,2 but
Ecker et al found no survival benefit from radiother-
apy.24 We analyzed 16 patients with intraspinal HPCs
who received adjuvant radiotherapy;7–10,13,15,17,19,20
9 had follow-up data, 5 of whom suffered from recur-
rence (56%). There was no significant difference from
those who had not received radiotherapy (52%,
p = 0.58). The role of radiotherapy is still uncertain.
Recently, stereotactic radiosurgery emerged as a use-
ful tool for intracranial HPCs. In 1993, Coffey et al29
reported the first series of patients in whom radio-
surgery was used to treat recurrent HPCs; an 82%
tumor control rate was noted. Payne et al30 reported
an 87% tumor control rate during a mean follow-up
of 2.5 years, and Ecker et al24 reported a 93% control
rate during a mean follow-up of 3.8 years. Radio-
surgery may be a good alternative to repeated surgery
in residual or recurrent cases.
In conclusion, we have reported a case of primary
intradural HPC with intramedullary invasion. Gross-
total removal was achieved, and no recurrence has
been noted up to the present time. A literature review
showed that intradural HPCs have a higher chance 
of total resection. There is no difference in recurrence
rate between extradural and intradural HPCs. Radio-
therapy does not appear to help in reducing recur-
rence rates. The rarity of this tumor in the spine,
specifically in the intradural region, makes further stud-
ies necessary. The ideal treatment has yet to be deter-
mined, but should be individualized for each specific
case.
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